Drug Profile
Reglitazar
Alternative Names: JTT 501; PNU 182716; PNU 716; reglixaneLatest Information Update: 20 Jan 2003
Price :
$50
*
At a glance
- Originator Japan Tobacco
- Developer Japan Tobacco; Pharmacia Corporation
- Class Antihyperglycaemics; Insulin sensitisers
- Mechanism of Action Peroxisome proliferator-activated receptor alpha agonists; Peroxisome proliferator-activated receptor gamma agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diabetes mellitus
Most Recent Events
- 24 Oct 2002 Discontinued - Phase-II for Diabetes mellitus in USA (unspecified route)
- 24 Oct 2002 Discontinued - Phase-II for Diabetes mellitus in Japan (unspecified route)
- 08 Nov 2001 Reglitazar is the pINN for PNU 716